Skip to main content
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1996 Oct;9(4):435–447. doi: 10.1128/cmr.9.4.435

Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.

M A Saubolle 1, T E Kiehn 1, M H White 1, M F Rudinsky 1, D Armstrong 1
PMCID: PMC172903  PMID: 8894345

Abstract

Reports of the association of Mycobacterium haemophilum with disease in humans have greatly increased. At least 64 cases have now been reported, with symptoms ranging from focal lesions to widespread, systemic disease. The organism is now known to cause primarily cutaneous and subcutaneous infection, septic arthritis, osteomyelitis, and pneumonitis in patients who are immunologically compromised and lymphadenitis in apparently immunocompetent children. Underlying conditions in the compromised patients have included AIDS; renal, bone marrow, and cardiac transplantation; lymphoma; rheumatoid arthritis; marrow hypoplasia; and Crohn's disease. Reports have originated from diverse geographic areas worldwide. The epidemiology of M. haemophilum remains poorly defined; there appears to be a genetic diversity between strains isolated from different regions. The organism is probably present in the environment, but recovery by sampling has not been successful. M. haemophilum has several unique traits, including predilection for lower temperatures (30 to 32 degrees C) and requirement for iron supplementation (ferric ammonium citrate or hemin). These may in the past have compromised recovery in the laboratory. Therapy has not been well elucidated, and the outcome appears to be influenced by the patient's underlying immunosuppression. The organisms are most susceptible to ciprofloxacin, clarithromycin, rifabutin, and rifampin. Timely diagnosis and therapy require communication between clinician and the laboratory.

Full Text

The Full Text of this article is available as a PDF (658.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott M. R., Smith D. D. Mycobacterial infections in immunosuppressed patients. Med J Aust. 1981 Apr 4;1(7):351–353. doi: 10.5694/j.1326-5377.1981.tb135629.x. [DOI] [PubMed] [Google Scholar]
  2. Abbott M. R., Smith D. D. The pathogenic effects of Mycobacterium haemophilum in immunosuppressed albino mice. J Med Microbiol. 1980 Nov;13(4):535–540. doi: 10.1099/00222615-13-4-535. [DOI] [PubMed] [Google Scholar]
  3. Abell F., Harrison P. B., Seldon M. Mycobacterium haemophilum infection in an elderly patient. Aust N Z J Med. 1994 Aug;24(4):404–404. doi: 10.1111/j.1445-5994.1994.tb01471.x. [DOI] [PubMed] [Google Scholar]
  4. Armstrong K. L., James R. W., Dawson D. J., Francis P. W., Masters B. Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. J Pediatr. 1992 Aug;121(2):202–205. doi: 10.1016/s0022-3476(05)81188-6. [DOI] [PubMed] [Google Scholar]
  5. Artenstein A. W., Fritzinger D., Gasser R. A., Jr, Skillman L. P., McEvoy P. L., Hadfield T. L. Infection due to Mycobacterium haemophilum identified by whole cell lipid analysis and nucleic acid sequencing. Clin Infect Dis. 1994 Dec;19(6):1155–1157. doi: 10.1093/clinids/19.6.1155. [DOI] [PubMed] [Google Scholar]
  6. Becherer P., Hopfer R. L. Infection with Mycobacterium haemophilum. Clin Infect Dis. 1992 Mar;14(3):793–793. doi: 10.1093/clinids/14.3.793. [DOI] [PubMed] [Google Scholar]
  7. Bernard E. M., Edwards F. F., Kiehn T. E., Brown S. T., Armstrong D. Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Antimicrob Agents Chemother. 1993 Nov;37(11):2323–2326. doi: 10.1128/aac.37.11.2323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Besra G. S., McNeil M., Minnikin D. E., Portaels F., Ridell M., Brennan P. J. Structural elucidation and antigenicity of a novel phenolic glycolipid antigen from Mycobacterium haemophilum. Biochemistry. 1991 Aug 6;30(31):7772–7777. doi: 10.1021/bi00245a015. [DOI] [PubMed] [Google Scholar]
  9. Branger B., Gouby A., Oulès R., Balducchi J. P., Mourad G., Fourcade J., Mion C., Duntz F., Ramuz M. Mycobacterium haemophilum and mycobacterium xenopi associated infection in a renal transplant patient. Clin Nephrol. 1985 Jan;23(1):46–49. [PubMed] [Google Scholar]
  10. Cage G. D. Direct identification of Mycobacterium species in BACTEC 7H12B medium by high-performance liquid chromatography. J Clin Microbiol. 1994 Feb;32(2):521–524. doi: 10.1128/jcm.32.2.521-524.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cooper D. K., Lanza R. P., Oliver S., Forder A. A., Rose A. G., Uys C. J., Novitzky D., Barnard C. N. Infectious complications after heart transplantation. Thorax. 1983 Nov;38(11):822–828. doi: 10.1136/thx.38.11.822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Damato J. J., Collins M. T. Radiometric studies with gas-liquid and thin-layer chromatography for rapid demonstration of hemin dependence and characterization of Mycobacterium haemophilum. J Clin Microbiol. 1984 Sep;20(3):515–518. doi: 10.1128/jcm.20.3.515-518.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Darling T. N., Sidhu-Malik N., Corey G. R., Allen N. B., Kamino H., Murray J. C. Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin. Br J Dermatol. 1994 Sep;131(3):376–379. doi: 10.1111/j.1365-2133.1994.tb08528.x. [DOI] [PubMed] [Google Scholar]
  14. Davis B. R., Brumbach J., Sanders W. J., Wolinsky E. Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med. 1982 Nov;97(5):723–724. doi: 10.7326/0003-4819-97-5-723. [DOI] [PubMed] [Google Scholar]
  15. Dawson D. J., Blacklock Z. M., Kane D. W. Mycobacterium haemophilum causing lymphadenitis in an otherwise healthy child. Med J Aust. 1981 Sep 19;2(6):289–290. doi: 10.5694/j.1326-5377.1981.tb128321.x. [DOI] [PubMed] [Google Scholar]
  16. Dawson D. J., Jennis F. Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum. J Clin Microbiol. 1980 Feb;11(2):190–192. doi: 10.1128/jcm.11.2.190-192.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dever L. L., Martin J. W., Seaworth B., Jorgensen J. H. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin Infect Dis. 1992 Jun;14(6):1195–1200. doi: 10.1093/clinids/14.6.1195. [DOI] [PubMed] [Google Scholar]
  18. Fischer L. J., Quinn F. D., White E. H., King C. H. Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B). Infect Immun. 1996 Jan;64(1):269–276. doi: 10.1128/iai.64.1.269-276.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gouby A., Branger B., Oules R., Ramuz M. Two cases of Mycobacterium haemophilum infection in a renal-dialysis unit. J Med Microbiol. 1988 Apr;25(4):299–300. doi: 10.1099/00222615-25-4-299. [DOI] [PubMed] [Google Scholar]
  20. Gupta I., Kocher J., Miller A. J., Weisholtz S. J., Perz J., Scully M. Mycobacterium haemophilum osteomyelitis in an AIDS patient. N J Med. 1992 Mar;89(3):201–202. [PubMed] [Google Scholar]
  21. Holton J., Nye P., Miller R. Mycobacterium haemophilum infection in a patient with AIDS. J Infect. 1991 Nov;23(3):303–306. doi: 10.1016/0163-4453(91)93080-v. [DOI] [PubMed] [Google Scholar]
  22. Kiehn T. E., White M. Mycobacterium haemophilum: an emerging pathogen. Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):925–931. doi: 10.1007/BF02111493. [DOI] [PubMed] [Google Scholar]
  23. Kiehn T. E., White M., Pursell K. J., Boone N., Tsivitis M., Brown A. E., Polsky B., Armstrong D. A cluster of four cases of Mycobacterium haemophilum infection. Eur J Clin Microbiol Infect Dis. 1993 Feb;12(2):114–118. doi: 10.1007/BF01967586. [DOI] [PubMed] [Google Scholar]
  24. Kikuchi K., Bernard E. M., Kiehn T. E., Armstrong D., Riley L. W. Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum. J Clin Microbiol. 1994 Jul;32(7):1763–1767. doi: 10.1128/jcm.32.7.1763-1767.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kristjansson M., Bieluch V. M., Byeff P. D. Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature. Rev Infect Dis. 1991 Sep-Oct;13(5):906–910. doi: 10.1093/clinids/13.5.906. [DOI] [PubMed] [Google Scholar]
  26. Lederman C., Spitz J. L., Scully B., Schulman L. L., Della-Latta P., Weitzman I., Grossman M. E. Mycobacterium haemophilum cellulitis in a heart transplant recipient. J Am Acad Dermatol. 1994 May;30(5 Pt 1):804–806. doi: 10.1016/s0190-9622(08)81522-8. [DOI] [PubMed] [Google Scholar]
  27. Lomwardias S., Madge G. E. Chaetoconidium and atypical acid-fast bacilli in skin ulcers. Arch Dermatol. 1972 Dec;106(6):875–876. doi: 10.1001/archderm.106.6.875. [DOI] [PubMed] [Google Scholar]
  28. Males B. M., West T. E., Bartholomew W. R. Mycobacterium haemophilum infection in a patient with acquired immune deficiency syndrome. J Clin Microbiol. 1987 Jan;25(1):186–190. doi: 10.1128/jcm.25.1.186-190.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. McBride J. A., McBride M. E., Wolf J. E., Jr Evaluation of commercial blood-containing media for cultivation of Mycobacterium haemophilum. Am J Clin Pathol. 1992 Sep;98(3):282–286. doi: 10.1093/ajcp/98.3.282. [DOI] [PubMed] [Google Scholar]
  30. McBride M. E., Rudolph A. H., Tschen J. A., Cernoch P., Davis J., Brown B. A., Wallace R. J., Jr Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections. Arch Dermatol. 1991 Feb;127(2):276–277. [PubMed] [Google Scholar]
  31. McGovern J., Bix B. C., Webster G. Mycobacterium haemophilum skin disease successfully treated with excision. J Am Acad Dermatol. 1994 Feb;30(2 Pt 1):269–270. doi: 10.1016/s0190-9622(08)81925-1. [DOI] [PubMed] [Google Scholar]
  32. Mezo A., Jennis F., McCarthy S. W., Dawson D. J. Unusual mycobacteria in 5 cases of opportunistic infections. Pathology. 1979 Jul;11(3):377–384. doi: 10.3109/00313027909059014. [DOI] [PubMed] [Google Scholar]
  33. Moulsdale M. T., Harper J. M., Thatcher G. N., Dunn B. L. Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillus. Tubercle. 1983 Mar;64(1):29–36. doi: 10.1016/0041-3879(83)90047-8. [DOI] [PubMed] [Google Scholar]
  34. Portaels F., Dawson D. J., Larsson L., Rigouts L. Biochemical properties and fatty acid composition of Mycobacterium haemophilum: study of 16 isolates from Australian patients. J Clin Microbiol. 1993 Jan;31(1):26–30. doi: 10.1128/jcm.31.1.26-30.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rogers P. L., Walker R. E., Lane H. C., Witebsky F. G., Kovacs J. A., Parrillo J. E., Masur H. Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome. Am J Med. 1988 Mar;84(3 Pt 2):640–642. doi: 10.1016/0002-9343(88)90150-7. [DOI] [PubMed] [Google Scholar]
  36. Ryan C. G., Dwyer B. W. New characteristics of Mycobacterium haemophilum. J Clin Microbiol. 1983 Oct;18(4):976–977. doi: 10.1128/jcm.18.4.976-977.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sompolinsky D., Lagziel A., Rosenberg I. Further studies of a new pathogenic mycobacterium (M. haemophilum sp. nov.). Can J Microbiol. 1979 Feb;25(2):217–226. doi: 10.1139/m79-033. [DOI] [PubMed] [Google Scholar]
  38. Soubani A. O., al-Marri M., Forlenza S. Successful treatment of disseminated Mycobacterium haemophilum infection in a patient with AIDS. Clin Infect Dis. 1994 Mar;18(3):475–476. doi: 10.1093/clinids/18.3.475. [DOI] [PubMed] [Google Scholar]
  39. Sowden D., Kemp R., Dawson D. Osteomyelitis due to Mycobacterium haemophilum in a patient with AIDS. Pathology. 1993 Jul;25(3):308–309. doi: 10.3109/00313029309066595. [DOI] [PubMed] [Google Scholar]
  40. Straus W. L., Ostroff S. M., Jernigan D. B., Kiehn T. E., Sordillo E. M., Armstrong D., Boone N., Schneider N., Kilburn J. O., Silcox V. A. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med. 1994 Jan 15;120(2):118–125. doi: 10.7326/0003-4819-120-2-199401150-00004. [DOI] [PubMed] [Google Scholar]
  41. Thibert L., Lapierre S. Routine application of high-performance liquid chromatography for identification of mycobacteria. J Clin Microbiol. 1993 Jul;31(7):1759–1763. doi: 10.1128/jcm.31.7.1759-1763.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Thibert L., Lebel F., Martineau B. Two cases of Mycobacterium haemophilum infection in Canada. J Clin Microbiol. 1990 Mar;28(3):621–623. doi: 10.1128/jcm.28.3.621-623.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Vadney F. S., Hawkins J. E. Evaluation of a simple method for growing Mycobacterium haemophilum. J Clin Microbiol. 1985 Nov;22(5):884–885. doi: 10.1128/jcm.22.5.884-885.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Walder B. K., Jeremy D., Charlesworth J. A., Macdonald G. J., Pussell B. A., Robertson M. R. The skin and immunosuppression. Australas J Dermatol. 1976 Dec;17(3):94–97. doi: 10.1111/j.1440-0960.1976.tb00798.x. [DOI] [PubMed] [Google Scholar]
  45. Wayne L. G., Sramek H. A. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev. 1992 Jan;5(1):1–25. doi: 10.1128/cmr.5.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. White M. H., Papadopoulos E. B., Small T. N., Kiehn T. E., Armstrong D. Mycobacterium haemophilum infections in bone marrow transplant recipients. Transplantation. 1995 Nov 15;60(9):957–960. [PubMed] [Google Scholar]
  47. White M. P., Bangash H., Goel K. M., Jenkins P. A. Non-tuberculous mycobacterial lymphadenitis. Arch Dis Child. 1986 Apr;61(4):368–371. doi: 10.1136/adc.61.4.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Yakrus M. A., Straus W. L. DNA polymorphisms detected in Mycobacterium haemophilum by pulsed-field gel electrophoresis. J Clin Microbiol. 1994 Apr;32(4):1083–1084. doi: 10.1128/jcm.32.4.1083-1084.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yarrish R. L., Shay W., LaBombardi V. J., Meyerson M., Miller D. K., Larone D. Osteomyelitis caused by Mycobacterium haemophilum: successful therapy in two patients with AIDS. AIDS. 1992 Jun;6(6):557–561. [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES